North America Hypodermic Needles Market Report and Forecast 2025-2034
Description
The North America hypodermic needles market was valued at USD 1630.30 Million in 2024 , driven by the increasing prevalence of chronic diseases and rising innovation in needle technology in the region. The market is expected to grow at a CAGR of 7.00% during the forecast period of 2025-2034, reaching a value of USD 3207.05 Million by 2034 .
North America Hypodermic Needles Market Analysis
Hypodermic needles are hollow needles utilized for fast delivery of fluids (medications or vaccines) into the patient’s body. They are also used for blood administration and transfusions. Older adults are more prone to developing a chronic condition that often requires frequent injections, leading to increased use of these medical tools in healthcare settings which impacts the global hypodermic needles market dynamics. Further, the rising improvements in needle manufacturing processes such as automation and precision engineering are expected to enhance the quality of this product and drive the North America hypodermic needles market growth.
In the United States, around 129 million people have at least 1 major chronic disease including cancer, heart disease, and hypertension. Further, the proportion of people living with multiple chronic conditions is increasing rapidly in America . The rising burden of chronic health issues augments the need for hypodermic needles for the efficient delivery of injectables. Moreover, there is a shift towards home healthcare, and the self-administration of medications, such as insulin for diabetes and biologics for autoimmune diseases, which directly influences the North America hypodermic needles market demand.
In January 2023, leading med-tech manufacturer MTD Group’s affiliate Pikdare S.p.A. received the United States Food and Drug Administration (FDA) approval for its innovative injection needle, DropSafe Sicura passive safety needle, which boasts a fully passive mechanism that can be utilized for the subcutaneous and intramuscular injection of vaccines and other drugs. This passive safety needle can help eliminate needlestick injuries, with the needle being protected by a transparent shield designed to lock automatically after injection. Thus, the healthcare professional doesn’t require any incremental activation step after the injection. The rising introduction of advanced passive safety-engineered devices for safe drug delivery is poised to elevate the market value in the forecast period.
North America Hypodermic Needles Market Segmentation
The EMR’s report titled “North America Hypodermic Needles Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Usage
The key features of the market report include partnerships, and collaborations analysis by the leading market players. The major companies in the market are as follows:
EXELINT International, Co.
This company manufactures and distributes disposable medical health care products including siliconized, autoground needle points to ensure maximum patient comfort.
Terumo Corporation
Terumo Corporation is a leading provider of medical devices and supplies. Its hypodermic needles are precision-manufactured to guarantee maximum sharpness.
Becton, Dickinson and Company
This American multinational medical technology company is a key manufacturer of high-quality and easy-to-use safety injection needles and syringes.
B. Braun Melsungen AG
This German medical and pharmaceutical device company has a prominent presence in the market. Its hypodermic needles have a light silicone coating to provide a smooth surface and minimize discomfort.
Other players in the market include Catalent Inc., Cardinal Health Inc., Vita Needle Company, Connecticut Hypodermics Inc., Vygon, Barber of Sheffield, and Retractable Technologies, Inc.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
North America Hypodermic Needles Market Analysis
Hypodermic needles are hollow needles utilized for fast delivery of fluids (medications or vaccines) into the patient’s body. They are also used for blood administration and transfusions. Older adults are more prone to developing a chronic condition that often requires frequent injections, leading to increased use of these medical tools in healthcare settings which impacts the global hypodermic needles market dynamics. Further, the rising improvements in needle manufacturing processes such as automation and precision engineering are expected to enhance the quality of this product and drive the North America hypodermic needles market growth.
In the United States, around 129 million people have at least 1 major chronic disease including cancer, heart disease, and hypertension. Further, the proportion of people living with multiple chronic conditions is increasing rapidly in America . The rising burden of chronic health issues augments the need for hypodermic needles for the efficient delivery of injectables. Moreover, there is a shift towards home healthcare, and the self-administration of medications, such as insulin for diabetes and biologics for autoimmune diseases, which directly influences the North America hypodermic needles market demand.
In January 2023, leading med-tech manufacturer MTD Group’s affiliate Pikdare S.p.A. received the United States Food and Drug Administration (FDA) approval for its innovative injection needle, DropSafe Sicura passive safety needle, which boasts a fully passive mechanism that can be utilized for the subcutaneous and intramuscular injection of vaccines and other drugs. This passive safety needle can help eliminate needlestick injuries, with the needle being protected by a transparent shield designed to lock automatically after injection. Thus, the healthcare professional doesn’t require any incremental activation step after the injection. The rising introduction of advanced passive safety-engineered devices for safe drug delivery is poised to elevate the market value in the forecast period.
North America Hypodermic Needles Market Segmentation
The EMR’s report titled “North America Hypodermic Needles Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Usage
- Disposable
- Reusable
- Others
- Safety Hypodermic Needles
- Non-Safety Hypodermic Needles
- Drug Delivery
- Vaccination
- Blood Specimen Collection
- Hospitals
- Cancer Treatments Centers
- Dermatology Clinics
- Others
- United States
- Canada
The key features of the market report include partnerships, and collaborations analysis by the leading market players. The major companies in the market are as follows:
EXELINT International, Co.
This company manufactures and distributes disposable medical health care products including siliconized, autoground needle points to ensure maximum patient comfort.
Terumo Corporation
Terumo Corporation is a leading provider of medical devices and supplies. Its hypodermic needles are precision-manufactured to guarantee maximum sharpness.
Becton, Dickinson and Company
This American multinational medical technology company is a key manufacturer of high-quality and easy-to-use safety injection needles and syringes.
B. Braun Melsungen AG
This German medical and pharmaceutical device company has a prominent presence in the market. Its hypodermic needles have a light silicone coating to provide a smooth surface and minimize discomfort.
Other players in the market include Catalent Inc., Cardinal Health Inc., Vita Needle Company, Connecticut Hypodermics Inc., Vygon, Barber of Sheffield, and Retractable Technologies, Inc.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
250 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 North America Hypodermic Needles Market Overview
- 3.1 North America Hypodermic Needles Market Historical Value (2018-2024)
- 3.2 North America Hypodermic Needles Market Forecast Value (2025-2034)
- 4 North America Hypodermic Needles Market Landscape*
- 4.1 North America Hypodermic Needles: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 North America Hypodermic Needles: Product Landscape
- 4.2.1 Analysis by Usage
- 4.2.2 Analysis by Product Type
- 5 North America Hypodermic Needles Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 North America Hypodermic Needles Market Segmentation (218-2034)
- 6.1 North America Hypodermic Needles Market (2018-2034) by Usage
- 6.1.1 Market Overview
- 6.1.2 Disposable
- 6.1.3 Reusable
- 6.1.4 Others
- 6.2 North America Hypodermic Needles Market (2018-2034) by Product Type
- 6.2.1 Market Overview
- 6.2.2 Safety Hypodermic Needles
- 6.2.3 Non-Safety Hypodermic Needles
- 6.3 North America Hypodermic Needles Market (2018-2034) by Application
- 6.3.1 Market Overview
- 6.3.2 Drug Delivery
- 6.3.2.1 Chemotherapy
- 6.3.2.2 Spinal /Epidural Infusion
- 6.3.2.3 Plastic surgery
- 6.3.3 Vaccination
- 6.3.4 Blood Specimen Collection
- 6.4 North America Hypodermic Needles Market (2018-2034) by End User
- 6.4.1 Market Overview
- 6.4.2 Hospitals
- 6.4.3 Cancer Treatments Centers
- 6.4.4 Dermatology Clinics
- 6.4.5 Others
- 6.5 North America Hypodermic Needles Market (2018-2034) by Country
- 6.5.1 Market Overview
- 6.5.2 United States
- 6.5.3 Canada
- 7 United States Hypodermic Needles Market (218-2034)
- 7.1 United States Hypodermic Needles Market (2018-2034) by Usage
- 7.1.1 Market Overview
- 7.1.2 Disposable
- 7.1.3 Reusable
- 7.1.4 Others
- 7.2 United States Hypodermic Needles Market (2018-2034) by Product Type
- 7.2.1 Market Overview
- 7.2.2 Safety Hypodermic Needles
- 7.2.3 Non-Safety Hypodermic Needles
- 7.3 United States Hypodermic Needles Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Drug Delivery
- 7.3.2.1 Chemotherapy
- 7.3.2.2 Spinal /Epidural Infusion
- 7.3.2.3 Plastic surgery
- 7.3.3 Vaccination
- 7.3.4 Blood Specimen Collection
- 7.4 United States Hypodermic Needles Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Hospitals
- 7.4.3 Cancer Treatments Centers
- 7.4.4 Dermatology Clinics
- 7.4.5 Others
- 8 Canada Hypodermic Needles Market (218-2034)
- 8.1 Canada Hypodermic Needles Market (2018-2034) by Usage
- 8.1.1 Market Overview
- 8.1.2 Disposable
- 8.1.3 Reusable
- 8.1.4 Others
- 8.2 Canada Hypodermic Needles Market (2018-2034) by Product Type
- 8.2.1 Market Overview
- 8.2.2 Safety Hypodermic Needles
- 8.2.3 Non-Safety Hypodermic Needles
- 8.3 Canada Hypodermic Needles Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Drug Delivery
- 8.3.2.1 Chemotherapy
- 8.3.2.2 Spinal /Epidural Infusion
- 8.3.2.3 Plastic surgery
- 8.3.3 Vaccination
- 8.3.4 Blood Specimen Collection
- 8.4 Canada Hypodermic Needles Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Hospitals
- 8.4.3 Cancer Treatments Centers
- 8.4.4 Dermatology Clinics
- 8.4.5 Others
- 9 Partnership and Collaborations Analysis
- 9.1 Analysis by Partnership Instances
- 9.2 Analysis by Type of Partnership
- 9.3 Analysis by Leading Players
- 9.4 Analysis by Geography
- 10 Supplier Landscape
- 10.1 Market Share by Top 5 Companies
- 10.2 EXELINT International, Co.
- 10.2.1 Financial Analysis
- 10.2.2 Product Portfolio
- 10.2.3 Demographic Reach and Achievements
- 10.2.4 Mergers and Acquisitions
- 10.2.5 Certifications
- 10.3 Terumo Corporation
- 10.3.1 Financial Analysis
- 10.3.2 Product Portfolio
- 10.3.3 Demographic Reach and Achievements
- 10.3.4 Mergers and Acquisitions
- 10.3.5 Certifications
- 10.4 Becton, Dickinson and Company
- 10.4.1 Financial Analysis
- 10.4.2 Product Portfolio
- 10.4.3 Demographic Reach and Achievements
- 10.4.4 Mergers and Acquisitions
- 10.4.5 Certifications
- 10.5 B. Braun Melsungen AG
- 10.5.1 Financial Analysis
- 10.5.2 Product Portfolio
- 10.5.3 Demographic Reach and Achievements
- 10.5.4 Mergers and Acquisitions
- 10.5.5 Certifications
- 10.6 Catalent Inc
- 10.6.1 Financial Analysis
- 10.6.2 Product Portfolio
- 10.6.3 Demographic Reach and Achievements
- 10.6.4 Mergers and Acquisitions
- 10.6.5 Certifications
- 10.7 Cardinal Health Inc
- 10.7.1 Financial Analysis
- 10.7.2 Product Portfolio
- 10.7.3 Demographic Reach and Achievements
- 10.7.4 Mergers and Acquisitions
- 10.7.5 Certifications
- 10.8 Vita Needle Company
- 10.8.1 Financial Analysis
- 10.8.2 Product Portfolio
- 10.8.3 Demographic Reach and Achievements
- 10.8.4 Mergers and Acquisitions
- 10.8.5 Certifications
- 10.9 Connecticut Hypodermics Inc.
- 10.9.1 Financial Analysis
- 10.9.2 Product Portfolio
- 10.9.3 Demographic Reach and Achievements
- 10.9.4 Mergers and Acquisitions
- 10.9.5 Certifications
- 10.10 Vygon
- 10.10.1 Financial Analysis
- 10.10.2 Product Portfolio
- 10.10.3 Demographic
- 10.10.4 Mergers and Acquisitions
- 10.10.5 Certifications
- 10.11 Barber of Sheffield
- 10.11.1 Financial Analysis
- 10.11.2 Product Portfolio
- 10.11.3 Demographic Reach and Achievements
- 10.11.4 Mergers and Acquisitions
- 10.11.5 Certifications
- 10.12 RETRACTABLE TECHNOLOGIES, INC.
- 10.12.1 Financial Analysis
- 10.12.2 Product Portfolio
- 10.12.3 Demographic
- 10.12.4 Mergers and Acquisitions
- 10.12.5 Certifications
- 11 North America Hypodermic Needles Market – Distribution Model (Additional Insight)
- 11.1 Overview
- 11.2 Potential Distributors
- 11.3 Key Parameters for Distribution Partner Assessment
- 12 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 13 Company Competitiveness Analysis (Additional Insight)
- 13.1 Very Small Companies
- 13.2 Small Companies
- 13.3 Mid-Sized Companies
- 13.4 Large Companies
- 13.5 Very Large Companies
- 14 Payment Methods (Additional Insight)
- 14.1 Government Funded
- 14.2 Private Insurance
- 14.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
